RIGL - Rigel Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts7776
Avg. Estimate-0.14-0.14-0.31-0.36
Low Estimate-0.15-0.16-0.39-0.44
High Estimate-0.13-0.12-0.24-0.32
Year Ago EPS-0.16-0.14-0.44-0.31
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6665
Avg. Estimate9.28M10.96M82.58M84.92M
Low Estimate9M9.96M65.77M52M
High Estimate9.77M12M86.65M110.01M
Year Ago Sales1.79MN/A44.51M82.58M
Sales Growth (year/est)419.30%N/A85.50%2.80%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.16-0.150.03-0.13
EPS Actual-0.16-0.140.03-0.11
Difference00.0100.02
Surprise %0.00%6.70%0.00%15.40%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.14-0.14-0.31-0.36
7 Days Ago-0.14-0.14-0.31-0.36
30 Days Ago-0.14-0.14-0.4-0.36
60 Days Ago-0.14-0.14-0.4-0.37
90 Days Ago-0.14-0.14-0.4-0.37
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days5273
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRIGLIndustrySectorS&P 500
Current Qtr.12.50%N/AN/A0.02
Next Qtr.N/AN/AN/A0.04
Current Year29.50%N/AN/A0.05
Next Year-16.10%N/AN/A0.10
Next 5 Years (per annum)70.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A